2016

Strenkowska M, Grzela R, Majewski M, Wnek K, Kowalska J, Lukaszewicz M, Zuberek J, Darzynkiewicz E, Kuhn AN, Sahin U, Jemielity J: Cap analogs modified with 1,2-dithiodiphosphate moiety protect mRNA from decapping and enhance its translational potential. Nucleic Acids Res. 2016 Nov 16; 44(20):9578-9590 Epub 2016 Oct 7.
DOI; PubMed

Show abstract

Waisman A, Hövelmeyer N, Diefenbach A, Schuppan D, Reddehase MJ, Kleinert H, Kaina B, Grabbe S, Galle PR, Theobald M, Zipp F, Sahin U, Türeci Ö, Kreiter S, Langguth P, Decker H, van Zandbergen G, Schild H: Past, present and future of immunology in Mainz. Cell Immunol 2016.
DOI; PubMed

Grabbe S, Haas H, Diken M, Kranz LM, Langguth P, Sahin U: Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma. Nanomedicine (Lond) 2016 Oct 11.
DOI; PubMed

Show abstract

Poschke I, Faryna M, Bergmann F, Flossdorf M, Lauenstein C, Hermes J, Hinz U, Hank T, Ehrenberg R, Volkmar M, Loewer M, Glimm H, Hackert T, Sprick MR, Höfer T, Trumpp A, Halama N, Hassel JC, Strobel O, Büchler M, Sahin U, Offringa R: Identification of a tumor-reactive T-cell repertoire in the immune infiltrate of patients with resectable pancreatic ductal adenocarcinoma. Oncoimmunology 5(12):e1240859 2016 Oct 7
DOI; PubMed

Show abstract

Liu Y, Loewer M, Aluru S, Schmidt BSNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations. BMC Syst Biol. 2016 Aug 1;10 Suppl 2:47.

DOI; PubMed

Show abstract

Selmi A, Vascotto F, Kautz-Neu K, Türeci Ö, Sahin U, von Stebut E, Diken M, Kreiter S: Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice.Cancer Immunol Immunother 2016 Jul 15.
DOI; PubMed

Show abstract

Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H, Grunwitz C, Vormehr M, Hüsemann Y, Selmi A, Kuhn AN, Buck J, Derhovanessian E, Rae R, Attig S, Diekmann J, Jabulowsky RA, Heesch S, Hassel J, Langguth P, Grabbe S, Huber C, Türeci Ö, Sahin U: Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 2016-06-01; advance online publication
DOI; PubMed

Show abstract

Kreiter S, Diken M, Selmi A, Petschenka J, Türeci Ö, Sahin U: FLT3 Ligand as a Molecular Adjuvant for Naked RNA Vaccines. Methods Mol Biol. 2016;1428:163-75
DOI; PubMed

Show abstract

Alrefai H, Muhammad K, Rudolf R, Pham DA, Klein-Hessling S, Patra AK, Avots A, Bukur V, Sahin U, Tenzer S, Goebeler M, Kerstan A, Serfling E: NFATc1 supports imiquimod-induced skin inflammation by suppressing IL-10 synthesis in B cells. Nat Commun. 2016 May 25;7:11724.
DOI; PubMed

Show abstract

Wirtz RM, Sihto H, Isola J, Heikkilä P, Kellokumpu-Lehtinen PL, Auvinen P, Turpeenniemi-Hujanen T, Jyrkkiö S, Lakis S, Schlombs K, Laible M, Weber S, Eidt S, Sahin U, Joensuu H: Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry. Breast Cancer Res Treat. 2016 May 24
DOI; PubMed

Show abstract

McCann KJ, Mander A, Cazaly A, Chudley L, Stasakova J, Thirdborough SM, King A, Lloyd-Evans P, Buxton E, Edwards C, Halford S, Bateman A, O’Callaghan A, Clive S, Anthoney A, Jodrell DI, Weinschenk T, Simon P, Sahin U, Thomas GJ, Stevenson FK, Ottensmeier CH: Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunological and Clinical Outcomes Clinical Cancer Research 2016
DOI; PubMed

Show abstract

Türeci Ö, Vormehr M, Diken M, Kreiter S, Huber C, Sahin U: Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines. Clinical Cancer Research 2016; 22(8):1885-96
DOI; PubMed

Show abstract

Knies D, Klobuch S, Xue SA, Birtel M, Echchannaoui H, Yildiz O, Omokoko T, Guillaume P, Romero P, Stauss H, Sahin U, Herr W, Theobald M, Thomas S, Voss RH: An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells. Oncotarget 2016.
DOI; PubMed

Show abstract

Kreiter S, Diken M, Pascolo S, Nair SK, Thielemans KM, Geall A: The RNA Vaccination Therapy: Advances in an Emerging FieldJournal of Immunology Research 2016.
DOI; PubMed

Show abstract

Kranz LM, Birtel M, Krienke C, Grunwitz C, Petschenka J, Reuter KC, van de Roemer N, Vascotto F, Vormehr M, Kreiter S, Diken M: CIMT 2015: The right patient for the right therapy – Report on the 13th annual meeting of the Association for Cancer Immunotherapy. Human vaccines & immunotherapeutics 2016, 12:213-221. DE
DOI; PubMed

Show abstract

Omokoko TA, Luxemburger U, Bardissi S, Simon P, Utsch M, Breitkreuz A, Türeci Ö, Sahin U: Luciferase mRNA Transfection of Antigen Presenting Cells Permits Sensitive Nonradioactive Measurement of Cellular and Humoral Cytotoxicity. J Immunol Res 2016, 2016:9540975.
DOI; PubMed

Show abstract

Wagner M, Jung J, Koslowski M, Türeci Ö, Tiwari VK, Sahin U: Chromatin Immunoprecipitation Assay to Identify Genomic Binding Sites of Regulatory Factors. Methods in molecular biology (Clifton, N.J.) 2016, 1366:53-65.
DOI; PubMed

Show abstract

Kloke BP, Kreiter S, Vormehr M, Diken M, Kuhn AN, Sahin U: Actively personalized cancer vaccines–the step into clinical application. Pharmazie 2016, 1:43-7.
PubMed

Show abstract